Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Figure 1 | BMC Cancer

Figure 1

From: Proliferation and survival molecules implicated in the inhibition of BRAF pathway in thyroid cancer cells harbouring different genetic mutations

Figure 1

Western-blot analysis of BRAF expression levels after RNAi treatment. BRAF protein expression is inhibited in cells treated with siRNA BRAF-C2 in comparison to the blank, transfection control and siRNA control. Inhibition of BRAF was efficient in all cell lines. No alteration was seen in the levels of RAF-1 protein. The figure presented is representative of at least three independent experiments.

Back to article page